Virtually all obstetrician-gynecologists participating in a national survey ask pregnant women whether they use alcohol; most obtain this information during an initial visit with a patient, a practice re commended by the American College of Obstetricians and Gynecologists (ACOG) and the American Academy of Pediatrics. Nevertheless, only 30% of obstetriciangynecologists feel very pre p a red to assess pregnant women's alcohol use, and 83% say that they need information on thre s holds at which prenatal drinking poses spec i fic threats to the pregnancy or the fetus. M o re o v e r, although the federal government has for 20 years advised pre g n a n t women to refrain from drinking, about half of doctors surveyed believe that occasional use of alcohol during pre g n a n c y will not increase the risk of several adverse outcomes.
1 ACOG conducted the survey in 1998 among a sample consisting of active members of the organization plus the members of an ACOG re s e a rch network of physicians who volunteer to participate in periodic, topical surveys. The survey asked doctors about their alcohol screening practices, their opinions about the level of use that puts women at risk of particular adverse outcomes, and their counseling and referral practices for pregnant women who drink moderately (i.e., have an average of 3-13 drinks weekly) or heavily (i.e., have 14 or more drinks per week or at least five drinks at any one time).
In all, 604 obstetrician-gynecologists completed the survey. Thre e -fifths of respondents were men, and nine in 10 were younger than 60. About one-quarter had graduated from medical school before 1973, half had graduated between 1973 and 1989, and one-quarter had graduated later.* Fifty-one percent worked in a group private practice; 21% in a solo private practice; 20% in a managed care organization, university or medical school, or government institution; and 8% in other settings. The questionnaire was mailed to ACOG fellows throughout the country; however, because of the sampling proced u re used, the final sample may not be re p resentative of the organization's membership.
Ninety-seven percent of re s p o n d e n t s said that they obtain information on alcohol use from all of their obstetric patients; 92% do this at the first prenatal visit. Obstetrician-gynecologists use one or m o re of a variety of approaches to alcohol s c reening: Forty-eight percent ask women whether they drink, 41% have a nonphysician staff member ask and 19% include the question on a form that patients fill out. Tw e n t y -t h ree percent use one of the standardized screening tools that are available to help physicians detect alcohol use among pregnant women.
If a pregnant patient says that she drinks, 90% of respondents ask about her level of alcohol consumption. The vast majority also talk with her about the adverse effects of prenatal alcohol use-86% if she is a moderate drinker and 97% if she drinks heavily. Similarly, high pro p o r t i o n s advise patients who drink to discontinue alcohol use while pregnant (83% for moderate drinkers and 92% for heavy drinkers) or to reduce their alcohol consumption (79% and 88%, respectively). Far f e w e r, however, refer women for tre a tment: Only 21% refer moderate drinkers, and 61% refer heavy drinkers.
P roviding education about the eff e c t s of drinking during pregnancy is not a ro utine practice for many physicians. While 50% offer information or advice to all p regnant women, 36% raise the issue only if they know or suspect that a patient uses alcohol. Thirteen percent of respondents o ffer education or advice about pre n a t a l drinking only to women with risk factors associated with alcohol consumption during pregnancy (a history of drug use or heavy drinking, or current smoking).
Although thresholds have not been established, the survey asked physicians how many drinks per week they think p regnant women can consume without inc reasing their risk of having a spontaneous abortion or of bearing an infant with central nervous system impairment, birth defects or fetal alcohol syndrome. For each of these outcomes, 26-31% of re s p o n d e n t s believe that any alcohol consumption is too much, and 16-28% are unsure. The remainder (46-56%) think that some alcohol consumption poses no risk; the average weekly number of drinks considere d safe ranged from 4.6 for spontaneous abortion and central nervous system impairment to 6.6 for fetal alcohol syndro m e .
The bulk of obstetrician-gynecologists surveyed (66%) feel somewhat prepared to assess women's alcohol use, but only 30% feel very pre p a red and 4% feel unp re p a red. The need for additional training in this area is one of the most frequently cited barriers to the provision of this service (mentioned by 65% of physicians); others are time limitations, concerns about patients' sensitivity to the subject and a lack of referral sources (50-70%). When asked what re s o u rces they need to i m p rove their ability to assess patients' alcohol consumption, 83% of re s p o n d e n t s said information on thresholds for poor pregnancy outcomes.
Twenty-seven percent of physicians think that medical school did not adequately prepare them to assess pregnant women's alcohol use; 35% consider their training on the subject adequate, and the rest believe that it was very good or outstanding. The more positively physicians view their training, the more likely they a re to use a standardized screening tool and to feel pre p a red to assess patients' alcohol use. The level of satisfaction with training is highest among physicians who graduated after 1989 and falls signific a n t l y among those who graduated earlier.
In analyses that adjusted for re s p o ndents' age, the re s e a rchers found few sigPregnancy and Alcohol: Many Obstetrician-Gynecologists Are Unsure About Risks or How to Assess Women's Use *These periods re flect the evolution of understanding of and education about alcohol use during pregnancy: Prior to 1973, fetal alcohol syndrome had not yet been documented. In the middle period, the first surgeon general's report on prenatal drinking was issued, and medical school curricula began to include information on the subject. The period since 1990 has been characterized by extensive warning labels on alcohol products and official government health advisories. moderate drinkers, to advise these women to discontinue or reduce their alcohol use, and to advise heavy drinkers to cut down (ratios, 0.7-0.9). Furthermore, they are m o re likely than those who graduated after 1989 to be unsure as to thresholds for adverse outcomes, to say they need training in alcohol assessment and counseling, and to say that a lack of insurance re i mbursement is a barrier to providing these services (1.4-1.7). They are 10 times as likely to feel that their medical school training in this area was inadequate (10.1).
F e w e r, and somewhat less striking, differences exist between those who graduated in [1973] [1974] [1975] [1976] [1977] [1978] [1979] [1980] [1981] [1982] [1983] [1984] [1985] [1986] [1987] [1988] [1989] and those who completed school later. Physicians who graduated in the middle period are less likely than those who graduated later to use a screening tool, feel pre p a red to assess alcohol use, discuss the adverse effects of alcohol with heavy drinkers and advise such women to reduce their alcohol consumption (0.5-0.9). They are about 50% more likely than their colleagues who graduated later to consider a lack of insurance reimbursement an obstacle to aln i ficant diff e rences between male and female physicians' practices re g a rding pre gnant patients who drink. Male doctors are about 10% less likely than females to advise moderate drinkers to stop drinking ( p revalence rate ratio, 0.9), and they are 19% less likely to mention referral sourc e s as a re s o u rce that would improve their ability to assess patients' alcohol use. H o w e v e r, men are 15% more likely than women to say that women who are pre gnant or trying to conceive should abstain from alcohol use.
The timing of physicians' medical education, however, is associated with several aspects of their alcohol assessment practices. When physicians' gender is taken into account, those who graduated b e f o re 1973 are nearly 80% less likely than those who graduated after 1989 to use a s t a n d a rdized screening tool and about 40% less likely to consider themselves very pre p a red to assess alcohol use (pre v alence rate ratios, 0.2 and 0.6, re s p e c t i v ely). These doctors are less likely than those who graduated most recently to discuss the adverse effects of alcohol use with cohol screening or counseling, and they are nearly three times as likely to consider their training inadequate.
The re s e a rchers observe that despite two decades of federal advisories on the h a z a rds of drinking during pre g n a n c y, "many physicians are not convinced that total abstinence from alcohol is necessary for pregnant women." To remedy this situation, they suggest that professional organizations and public health agencies participate in "meaningful dialogue" about the issue and that federal, pro f e ssional and nonpro fit agencies collaborate to raise awareness of the potential eff e c t s of prenatal alcohol use. Furthermore, they note the importance of physicians' being kept up to date on the effects of drinking during pregnancy, on ways to assess patients' alcohol use and on interventions to use when they see pregnant patients who drink. -D. Hollander 
Experts Say Japan's Medical Delivery System Is Partly To Blame for High Level of Maternal Mortality There
In 1991-1992, 230 Japanese women died while pregnant or within 42 days after their pregnancy ended; the resulting maternal mortality rate of 9.5 deaths per 100,000 live births is somewhat higher than rates in other developed countries at roughly the same time. More o v e r, acc o rding to the results of an inquiry initiated by the Japanese government, nearly two in five maternal deaths that occurre d in medical facilities could have been prevented. Findings from the inquiry highlight how inadequacies in Japan's system of delivering obstetric care contribute to the risk of pregnancy-related death. 1 A 15-member study group was convened to conduct the inquiry, using data from death certificates to identify maternal deaths. The group investigated the details of each case by sending a questionn a i re to the medical facility that pro v i d e d care to the woman or, in instances where the woman had not received care, to the c o ro n e r's office. In addition to examining the characteristics of women who died and the causes of death, the group assessed characteristics of medical facilities involved, such as staffing patterns and the availability of laboratory services. Finall y, the re s e a rchers invited a panel of 42 medical specialists to review the records of women who died in medical facilities and assess how preventable each death was (using the categories impossible to prevent, difficult to prevent, not difficult to prevent or indeterminable).
In all, 230 maternal deaths occurred in Japan-9.5 for every 100,000 live birthsduring the period 1991-1992. While most of the women (197) had received care and died in medical facilities, 22 died outside a facility; information on 11 women was unavailable. Among women who died in hospitals or clinics, 80% had received re gular prenatal care; 58% had given birth p re v i o u s l y. Thirty-seven percent of these women had a cesarean delivery, the same p roportion delivered vaginally and 26% died before giving birth. The most common cause of death among women who had received medical care was prenatal or postpartum hemorrhage (38%); a variety of other direct and indirect causes each accounted for fewer than 15% of deaths. S i m i l a r l y, postpartum hemorrhage was the most frequent cause of death among women who had not received medical attention.
Of the 197 deaths that occurred in medical facilities, the panel of medical experts deemed 72 (37%) preventable: Panel members unanimously characterized 19 deaths as not difficult to prevent, and at least 70% of these specialists characterized an additional 53 deaths in this way. Thirty-two deaths (16% of those occurring in medical facilities) were judged possibly preventable, and the remainder unpreventable. As was the case overall, most p reventable deaths were attributable to hemorrhage.
Japanese hospitals and clinics that provide obstetric care have, on average, only one obstetrician on duty at a time, and a majority have no anesthesiologist. As a result, one doctor often serves as both obstetrician and anesthesiologist, and this was true for about two-thirds of women whose deaths were preventable (46 with h e m o r rhage and three with complications f rom anesthesia). In addition, the medical experts determined that 63% of preventable deaths were associated with deficiencies in hospital care, 10-13% with deficiencies in ambulatory or inpatient care and 50% with failure to meet basic practice standards.
The rate of unpreventable deaths was highest (12.9 per 100,000 live births) in facilities with at least four obstetricians, but the highest rate of preventable deaths was found in hospitals and clinics with only one obstetrician (4.1 per 100,000). Pre-
Family Planning Perspectives
Digests Adolescent males in the United States do not routinely receive re p roductive health services such as counseling by a medical p rofessional and testing for HIV or for other sexually transmitted diseases (STDs), even though they are likely to receive other health care services. 1 In a nationally re p resentative sample of 15-19-y e a r-olds, 71% had had a physical examination in the past year, but only 39% had received any re p roductive health services. Even among those who were sexually active, 71% had recently underg o n e a physical, yet only half had received rep roductive health services. Black teenagers had increased odds of re c e i v i n g every type of re p roductive health service examined-an encouraging finding, the investigators note, that contradicts re s u l t s of other research and suggests that these young men are able to overcome barriers to health care.
The 1,652 adolescents in the sample w e re identified in the 1995 National Survey of Adolescent Males, which was conducted among a population-based sample of 15-19-year-olds. The youths completed an interview and questionnaire concerning demographic characteristics and sexual behaviors. They were asked whether in the past year they had had a physical examination, an HIV test, another STD test or a discussion with a physician or nurse about any of four re p ro d u c t i v e health topics (condoms and the pre v e ntion of pre g n a n c y, AIDS and other STDs).
The investigators tested the influ e n c e of several types of factors on the re c e i p t of reproductive health services. They selected variables that might re flect knowlventable maternal deaths due to hemorrhage also occurred with greatest frequency at facilities with only one obstetrician (3.8 per 100,000), while no such deaths occurred at facilities with four or more obstetricians.
Additional analyses provided further insights into the relationship between maternal deaths and hospital or clinic characteristics. For example, the proportion of preventable deaths declined as the number of either obstetricians or anesthesiologists at a facility gre w. Furthermore, the rate of preventable deaths was considerably higher at facilities that transfer patients elsewhere before they die (56 per 100,000) than at facilities to which patients a re re f e r red (four per 100,000). Finally, faedge about and attitudes toward health and the health care system (e.g., race and e t h n i c i t y, parents' education, receipt of public assistance and knowledge of various re p roductive topics), accessibility of health care (e.g., area of residence, health insurance status and typical source of c a re) and the need for services (whether respondents had had a serious illness or i n j u r y, whether they had exhibited symptoms of an STD and the number of female sexual partners they had had in the last 12 months).
In the sample as a whole, 73% of youths w e re non-Hispanic whites, 14% were nonHispanic blacks and 13% were Hispanics. Roughly 70-80% were not dependent on public assistance, were covered by private insurance and had no contact with anyone who had AIDS; nearly nine in 10 had a regular source of health care. Only 20% of the sample had been ill or injured during the past year, and 10% had had STD symptoms; 50% had had a female sexual partner.
Although 71% of the young men had had a physical examination in the past y e a r, only 39% had received re p ro d u c t i v e health services. In all, 17% had had an HIV test, 11% had been tested for another STD and 29% had discussed at least one rep roductive issue with a physician or nurse. Notably, only 14% had discussed all four re p roductive issues with a professional. Even among sexually active teenagers, 71% had had a physical, but half had had no testing or relevant discussions with a professional.
Using logistic re g ression analyses, the investigators examined the re l a t i o n s h i p
Reproductive Health Services Typically Are Not Part of Male Teenagers' Routine Medical Care
cilities where maternal deaths occurre d w e re unlikely to have basic laboratory services available around the clock.
As a result of their inquiry, the res e a rchers propose several changes in Japan's medical delivery system. They re commend the establishment of regional obstetric facilities with increased physician coverage 24 hours a day. They further suggest that all facilities providing delivery c a re be staffed with at least one obstetrician and one provider of related nonobstetric care, and that these facilities be equipped to perform "essential laboratory services." Another proposal, stemming f rom a lack of uniformity in reporting of maternal deaths, is that all death certificates include standard classifications of obstetric and pre g n a n c y -related deaths. F i n a l l y, the study group urges the government and the Japanese Society of Obstetrics and Gynecology to collaborate on the development of "clear community practice standards that delineate specific s t a ffing and laboratory services necessary in each type of medical facility." While acknowledging the inevitability of some maternal deaths, the group members conclude that a systemic approach to change should reduce the occurrence of these events.-D. Hollander of each variable to the receipt of re p roductive health services while controlling for all of the other variables studied. They found that adolescents' odds of having had a re p roductive health discussion were roughly doubled if they had had symptoms of an STD or had engaged in sexual activity with more than one woman (odds ratios, 1.9-2.3). Odds also were elevated among adolescents who were black, had learned about sexual topics in school or f rom parents, received Medicaid or had had a recent illness or injury (odds ratios, 1.2-1.6). Young men from the Midwest had reduced odds of having talked with a medical professional about re p ro d u c t i v e health (0.5).
Adolescents became increasingly likely to have had an HIV test as they gre w older (1.2), and their odds of having received this service roughly doubled if they knew a person with AIDS, re c e i v e d Medicaid or had had 1-2 sexual partners in the previous year (1.7-2.2). The odds also were elevated for adolescents who had recently had three or more sexual partners (4.7). Additionally, relative to white youths who had not had a physical, white teenagers who had had an examination were more likely to have been tested for HIV, and black teenagers had elevated odds of HIV testing, re g a rdless of whether they had had a physical.
The odds of STD testing diff e red by ethn i c i t y, and the re s e a rchers there f o re conducted separate analyses for non-Hispanic and Hispanic young men. Among non-Hispanic adolescents, blacks were sign i ficantly more likely than whites to have been tested for STDs in the past year (odds S i m i l a r l y, evidence from another case-cont rol study suggests that ever-use of oral contraceptives reduces the odds of nonc a n c e rous ovarian tumors by 20%, and the d e c rease in risk is independent of estrogen dose.
2 In both studies, the magnitude of protection increased with longer durations of pill use.
Ovarian Cancer
The ovarian cancer study was based on data for women aged 20-69 who were t reated for epithelial ovarian cancer between 1994 and 1998 at 39 hospitals in D e l a w a re, New Jersey and Pennsylvania. Eligible women had received their diagnosis within the previous six months, and all diagnoses were confirmed pathologically. The control group consisted of randomly selected women who were matched to ovarian cancer patients by five-year age-group and telephone exchange (for those younger than 65) or by county of residence (for 65-69-year-o l d s ) . R e s e a rchers interviewed all participants to gather information on their demographic characteristics, sexual and re p roductive history, family cancer history and contraceptive use, including the brand of any oral contraceptive used. The analyses include interview data from 767 women with ovarian cancer and 1,367 controls.
To assess the effects of diff e rent hormone doses in combined oral contraceptives, the re s e a rchers classified pills as follows: Preparations containing less than 50 mcg of ethinyl estradiol or less than 100 mcg of mestranol were considered to have a low dose of estrogen; all others were cons i d e red high-dose estrogen pills. The progestin dose was considered low if the p rogestin was estimated to be less potent than 0.5 mg of norgestrel and was classified as high otherwise.
Some 80-90% of both cancer patients and controls were aged 40 or older, were white and had at least a high school education. Roughly three-quarters of cancer patients and nine in 10 controls had ever been pregnant. In all, 56% of women with ovarian cancer had ever used oral contraceptives, as had 69% of controls; the majority of pill users had taken pills containing low doses of both estrogen and progestin.
In analyses adjusting for age, race, pre gnancy history and family history of ovarian cancer, women who had ever used oral contraceptives had a 40% lower risk of ovarian cancer than women who had never used the pill (odds ratio, 0.6). The p rotective effect increased with the duration of use: Women had a 30% decrease in ratio, 1.6). Non-Hispanic teenagers also had elevated odds of STD testing if they were receiving public assistance, knew a person with AIDS, were covered by Medicaid, had no regular source of health care or had recently had 1-2 sexual partners (1.8-2.9). Those who recently had had three or more sexual partners or had undergone a physical examination were even more likely to have had an STD test (4.4-5.6).
Hispanic adolescents had incre a s e d odds of STD testing if their parents had a college education (2.9), if they had had a recent physical examination (7.2) or if they reported three or more sexual partners (9.0). Hispanic young men living in a ru r a l community and those without health insurance were significantly less likely than others to have been tested for STDs (0.1 and 0.2, respectively).
The investigators emphasize that despite some encouraging results from their analyses, few adolescent males receive re p roductive health care. Noting that services such as birth control counseling still are not c o n s i d e red an integral part of routine medical visits for young men (as they generally are for young women), they urge physicians to remedy this problem in accord a n c e with current guidelines. They conclude by recommending that "given the high rates of STDs and unintended pregnancy among U.S. teens and their receptiveness to sexual health counseling in a clinical context, it should be common practice to incorporate re p roductive health education into the ro utine health services of all adolescents."-L. Ninger risk (odds ratio, 0.7) if they had used the pill for up to four years and a 70% dec rease (0.3) if they had used it for 10 or m o re years. Of note, the risk of ovarian cancer was reduced by 30% even after less than one year of oral contraceptive use, and it remained lowered for 30 years after termination of use.
The degree of protection against ovarian cancer was similar whether women began using the pill before 1972, when hormone doses were generally high (odds ratio, 0.7); between 1972 and 1980, when l o w e r-dose formulations were being int roduced (0.5); or after 1980, when lowdose pills dominated the market (0.6). M o re o v e r, it varied little with diff e re n t doses of estrogen and progestin. Women who used formulations with either high doses or low doses of both hormones experienced a 50% decrease in cancer risk (odds ratio, 0.5). Regimens with a high estrogen and low progestin dose provided a 30% decrease in risk (0.7), and lowe s t rogen, high-progestin pills lowered the risk by 40% (0.6).
When the data were further adjusted for duration of pill use, women still had similar reductions in ovarian cancer risk reg a rdless of whether they used pills with high or low estrogen and progestin doses. Neither age at initiation of use nor duration since last use altered the protective effect of oral contraceptives.
The investigators note that their study is one of the first with a large group of patients and sufficiently long follow-up to evaluate the impact of low-dose oral contraceptives in comparison with that of high-dose formulations. Despite the difficulty in ascertaining pill brands many years after use, they conclude that lowdose preparations are as effective as highdose oral contraceptives in pre v e n t i n g ovarian cancer.
Benign Ovarian Tumors A total of 746 women aged 18-74 with surgically confirmed benign ovarian tumors w e re studied at six hospitals in the New York City area between 1992 and 1993. A group of 404 women, randomly selected from among those receiving gynecologic c a re at the same hospitals and fre q u e n c ymatched to the subjects' age distribution, served as controls. Interviews were conducted to ascertain the women's background characteristics, reproductive hist o r y, personal and family medical histories and details about combined oral contraceptive use.
Women who had ever used oral contraceptives had a 20% lower risk of de-
Low-and High-Dose Pills Are Equally Protective Against Ovarian Cancer
Women who have ever used the types of oral contraceptives that are common t o d a y, which contain low doses of estrogen and progestin, are 50% less likely than n e v e r-users of the pill to develop ovarian cancer; this level of protection is identical to that aff o rded by older oral contraceptives with higher hormone doses. 1 These findings, from a population-based, casec o n t rol study, suggest that one of the main noncontraceptive benefits of the pill-its ability to prevent ovarian cancer-has been unaffected by changes made in pill formulations to make the method safer. past. Again, the effect increased as duration of use rose and was most prominent for women who had used oral contraceptives for more than five years (odds ratio, 0.6).
F i n a l l y, the re s e a rchers assessed the impact of estrogen dose on the risk of n o n c a n c e rous ovarian tumors. (They were unable to include progestin in the dosage analysis because the numbers of women who had taken pills with any particular p rogestin were small.) No diff e rences in the tumor risk were found between veloping benign ovarian tumors than n e v e r-users of the pill (odds ratio, 0.8). Although a protective effect was not evident for women who reported current use of up to five years, the analysts found a s t rong trend of decreasing risk as duration of use increased; women who had been c u r rent users for more than five years were 60% less likely than never-users to develop benign ovarian tumors.
The pill's protective effect persisted even for women who had stopped using the method more than five years in the women who had used high-dose pill formulations and those who had used oral contraceptives containing low doses of estrogen. -L. Ninger 
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Hormonal contraceptives have only small, reversible effects on bone density, according to a multicenter study conducted in Africa, Asia and Latin America. 1 C o mp a red with women who do not use hormonal methods, women who use combined oral contraceptives experience a s i g n i ficant increase in bone density, while those who use the injectable depot m e d ro x y p ro g e s t e rone acetate (DMPA) or the levonorg e s t rel implant experience a sign i ficant decrease. These changes disappear after the first 2-3 years of current use and appear to be clinically insignific a n t .
A total of 2,545 women aged 30-34 were e n rolled between 1994 and 1997 at family planning clinics in Bangladesh, Brazil, China, Egypt, Mexico, Thailand and Zimbabwe. During interviews, each woman p rovided information on her social and demographic characteristics, obstetric and contraceptive history, dietary habits, and height and weight. Seventy-one women were excluded because they were currently pre gnant or lactating (or had been within the prior six months), had undergone hyst e rectomy or oophore c t o m y, or reported diseases or drug intake that could influence calcium metabolism.
The remaining 2,474 women were categorized as users of hormonal contraceptives if they had used hormonal contraceptives for at least two years over their lifetime and as never-users if their lifetime e x p o s u re amounted to no more than six months. Study participants who had used m o re than one hormonal contraceptive w e re assigned to the method most recently used for at least two years. Thus, 33% were classified as pill users, 14% as D M PA users and 25% as implant users, while 28% were considered never-users.
To determine bone density, the radius was measured near the wrist and the ulna was measured at midshaft. The average bone density at both sites diff e red significantly by country, with women in Zimbabwe having the highest values at both the radius and the ulna and women in Bangladesh having the lowest values. As a group, Asian centers (those in Bangladesh, China and Thailand) had the lowest bone density readings of any re g i o n .
When the data were adjusted for study center, an analysis of covariance showed that bone density at both the radius and the ulna was associated with body mass index, age, total months of lactation, total months since last lactation and the occupation of the woman's partner. Parity and coffee consumption were related to bone density at the radius only. Bone density at both sites was associated with hormonal method use: Values were highest for women who did not use hormonal contraceptives, followed by those who re l i e d on the pill, those who used the implant and those who relied on the injectable.
Most of these associations persisted after adjustment for the other variables in the analysis. Bone density values for women who relied on the pill (both all users and exclusive users) were not significantly diff e rent from those for never-users. Women who used DMPA had lower bone density; only the diff e rence at the radius was signific a n t for all users, while the diff e rences at both the radius and the ulna were significant for exclusive users. Women whose only hormonal method had been the levonorg e s t re l implant had significantly lower bone density at the ulna. The decrease in bone density for women who used DMPA or levo n o rg e s t rel was approximately 0.01 g/cm 2 , a relatively small decline, given that a dec rease of one standard deviation below the m e a s u rements in never-users equals app roximately 0.05 g/cm 2 . Further analysis of bone density for exclusive users and never-users revealed a pattern of significant change for all three methods during short-term current use. Wo m e n who had been using the pill for only 2-3 years had higher values at both bone sites than did never-users, while women who had been relying on either DMPA or the levo n o rg e s t rel implant for a similar period had s i g n i ficantly lower values than never-u s e r s at both bone sites. No other diff e rences in bone density were found for any of the contraceptive methods for longer durations of c u r rent or past use, which suggests that such changes are reversible over time.
A c c o rding to the re s e a rchers, the study's limitations include its cross-sectional design, the limited age range of the participants and the lack of bone density measurements at the femoral neck and spine. They note that the substantial variations across countries remain unexplained because several potentially important variables were not exp l o red, such as calcium intake, dietary habits in childhood and exercise. The women displayed minimal variation in smoking and alcohol consumption, so the potential influence of these variables on bone density could not be determined.
The investigators point out that the small decreases in bone density found in this study among women using the implant and the injectable are not considere d abnormal and fall short of the defin i t i o n of low bone mass-and well short of that for osteoporosis. They conclude that the changes in bone density observed soon after the beginning of hormonal contraceptive use appear to be temporary and clinically insignificant.-L. Ninger 
